Heart Disease
Daniel B. Sims
<p class="MsoNormal">Daniel Sims, MD, FAHA, FACC, serves as the Program Director of the Cardiology Fellowship Training Program and is the Medical Director of the Moses Cardiac Intensive Care Unit (CICU). Dr. Sims is an Associate Professor of Medicine, Fellow of the American Heart Association (AHA), and Fellow of the American College of Cardiology (ACC). Originally from Bellmore, NY, Dr. Sims graduated from Yale University with a BA in history in 1999. He attended medical school at Emory University School of Medicine in Atlanta, GA, graduating in 2003. He stayed at Emory for his 3-year internal medicine internship and residency training, finishing in 2006. He was selected to stay an additional one year to serve as the chief resident at the Emory University Hospital. Dr. Sims did his 3-year cardiology fellowship at Columbia University Medical Center and served as chief cardiology fellow during his final year, finishing in 2010. He completed an additional one-year advanced heart failure and transplant cardiology fellowship at Columbia in 2011. Dr. Sims returned to Emory to serve on the cardiology faculty and as a member of the Center for Heart Failure Therapy and Transplantation.</p>
<p class="MsoNormal">After 2 years, Dr. Sims was recruited to Montefiore in 2013 to be the Medical Director for the Moses CICU and a member of the cardiac transplant and left ventricular assist device (LVAD) team. At Montefiore, Dr. Sims has been active in clinical research involving heart failure, cardiogenic shock, cardiac critical care, cardiac transplantation, and LVADs. He has mentored numerous residents and fellows on research projects. Dr. Sims served 2 2-year terms as a member of the AHA’s Acute Cardiac Care Committee and has been a member of the AHA writing groups for scientific statements on neuroprognostication after cardiac arrest, management of fulminant myocarditis, the prevention of complications in the CICU, and escalating and de-escalating temporary mechanical circulatory support devices. Dr. Sims is a two-time winner of the Department of Medicine’s Sharon R. Silbiger Faculty Teaching Award as the subspecialist of the year. Prior to becoming Program Director, Dr. Sims was a two-time winner of the Cardiology Fellowship Training Program “Program Director’s Training Award.” Dr. Sims is board certified in Cardiology as well as in Advanced Heart Failure and Transplant Cardiology. </p>
Dr. Sim's clinical focus has been the treatment of patients with acute and chronic heart failure due to multiple kinds of cardiomyopathy such as dilated, hypertrophic and restrictive, among others.
Dr. Sims’ research focuses on a number of topics, including the delivery of cardiac critical care and improving outcomes in the CICU and the use of temporary mechanical circulatory support with intra-aortic balloon pumps, Impella, percutaneous heart pumps, extracorporeal membrane oxygenation (ECMO) pumps and other devices to treat cardiogenic shock. He also aims to improve left ventricular assist device patient and heart transplant patient survival.
<p>Daniel Sims, MD, serves as the Program Director of the Cardiology Fellowship Training Program and is the Medical Director of the Moses Cardiac Intensive Care Unit (CICU). Dr. Sims is an Associate Professor of Medicine at our Albert Einstein College of Medicine, Fellow of the American Heart Association (AHA), and Fellow of the American College of Cardiology (ACC). Originally from Bellmore, NY, Dr. Sims graduated from Yale University with a BA in history in 1999. He attended medical school at Emory University School of Medicine in Atlanta, GA, graduating in 2003. He stayed at Emory for his 3-year internal medicine internship and residency training, finishing in 2006. He was selected to stay an additional one year to serve as the chief resident at the Emory University Hospital. Dr. Sims did his 3-year cardiology fellowship at Columbia University Medical Center and served as chief cardiology fellow during his final year, finishing in 2010. He completed an additional one-year advanced heart failure and transplant cardiology fellowship at Columbia in 2011. Dr. Sims returned to Emory to serve on the cardiology faculty and as a member of the Center for Heart Failure Therapy and Transplantation.</p><p>After 2 years, Dr. Sims was recruited to Montefiore in 2013 to be the Medical Director for the Moses CICU and a member of the cardiac transplant and left ventricular assist device (LVAD) team. His clinical focus has been the treatment of patients with acute and chronic heart failure due to multiple kinds of cardiomyopathy such as dilated, hypertrophic, and restrictive, among others. Dr. Sims also cares for patients with myocarditis, left ventricular assist devices, and cardiac transplants.</p><p>Dr. Sims has been active in clinical research involving heart failure, cardiogenic shock, temporary mechanical circulatory support devices, cardiac critical care, cardiac transplantation, and LVADs. He has mentored numerous residents and fellows on research projects and his work has been published in a number of peer-reviewed journals and textbooks. Dr. Sims served 2 2-year terms as a member of the AHA’s Acute Cardiac Care Committee and has been a member of the AHA writing groups for scientific statements on neuroprognostication after cardiac arrest, management of fulminant myocarditis, the prevention of complications in the CICU, and escalating and de-escalating temporary mechanical circulatory support devices. Dr. Sims is a two-time winner of the Department of Medicine’s Sharon R. Silbiger Faculty Teaching Award as the subspecialist of the year. Prior to becoming Program Director, Dr. Sims was a two-time winner of the Cardiology Fellowship Training Program “Program Director’s Training Award.” Dr. Sims is a member of the AHA, the ACC, and the International Society of Heart and Lung Transplantation. Additionally, he is board certified in Cardiology as well as Advanced Heart Failure and Transplant Cardiology.</p>
Mark Shlomovich
Albumin Dialysis
Care of children before and after solid organ transplantation
<p>Mark Shlomovich, MD, is Director, Extracorporeal Liver Support and Director, Pediatric Critical Care Transport at Children’s Hospital at Montefiore and Assistant Professor, Pediatrics at Montefiore-Einstein. Dr. Shlomovich’s clinical focus is on the care of critically ill children with abdominal organ failure, transplantation and post-surgical care. He also focuses on the safe transportation of critically ill children.</p><p>In 2006, Dr. Shlomovich earned his Bachelor of Science in biology from Towson University. He then attended University of Connecticut School of Medicine earning his Doctor of Medicine in 2010. His postgraduate training began at SUNY Downstate Medical Center with a four-year pediatric residency, where he was Chief Pediatric Resident in his final year. He then came to Children's Hospital at Montefiore for a pediatric critical care fellowship, which he completed in 2017.</p><p>Dr. Shlomovich’s research interests are in the use of artificial liver support technology, as well as the care of children in liver failure before and after transplantation. In addition, he investigates the safety and efficiency of the transportation of critically ill children. He has shared his research through peer-reviewed journals and abstracts, and is an ad hoc reviewer for BMC Nephrology.</p><p>Dr. Shlomovich is board certified in general pediatrics and pediatric critical care medicine. He is a member of the Society of Critical Care Medicine and the American Academy of Pediatrics.</p>
Jooyoung (Julia) Shin
<p align="left" style=" word-break: normal; text-align: left;"><span style=" color: black; font-size: 12.0pt; font-family: 'Times New Roman';">Clinical cardiology, specifically end-stage congestive heart failure, mechanical circulatory support, and cardiac transplantation.  </span></p>
Dr. Shin's clinical focus is on caring for patients with heart failure, particularly providing expertise in advanced heart failure, heart transplantation, and mechanical circulatory support.
Heart failure treatment is the primary focus of Dr. Shin’s research. She is the site principal investigator for the effectiveness of omecamtiv mecarbil/AMG 423 to treat chronic heart failure with reduced ejection fraction (GALACTIC-HF) and multiple cardiac sensors for the management of heart failure (MANAGE-HF) trials.
<p>Jooyoung Julia Shin, MD, is Fellowship Director, Advanced Heart Failure and Transplant Cardiology Fellowship Program and Associate Professor, Medicine at Montefiore Einstein. Dr. Shin’s clinical focus centers on heart failure, cardiac transplantation and mechanical circulatory support.</p><p>After obtaining her Bachelor of Science from the University of Michigan in 1994, Dr. Shin earned her Doctor of Medicine at George Washington University in 1999. She completed an internship and residency in internal medicine at the University of Maryland in 2002 before completing a cardiovascular disease fellowship at Emory University in 2005. Following this, Dr. Shin remained at Emory to complete an additional fellowship in advanced heart failure and transplant cardiology in 2006.</p><p>Dr. Shin’s research focuses on fellow education. She has been principal investigator and co-principal investigator on several funded research projects, and she has presented at invited lectures nationwide. Her work has also been published in numerous peer-reviewed journals, and she has been a reviewer for scientific publications, including the <em>Mayo Clinic Proceedings</em>, the <em>American Journal of Cardiology</em> and <em>Pacing and Clinical Electrophysiology</em>, among others.</p><p>Dr. Shin is board certified by the American Board of Internal Medicine in Cardiovascular Disease, Internal Medicine and Advanced Heart Failure and Transplant Cardiology. She is a member of the American College of Cardiology and the International Society for Heart and Lung Transplantation.</p>
Aldo L. Schenone
Orna Rosen
Carlos J. Rodriguez
Dr. Rodriguez’s clinical focus is general cardiology, echocardiology, hypertension, heart failure and cholesterol management.
Expanding on his clinical focus, Dr. Rodriguez’s research investigates cardiovascular epidemiology and the impact of psychosocial and behavioral factors on cardiovascular health.
<p>Carlos Jose Rodriguez, MD, MPH, FAHA, FACC, is Director, Cardiovascular Epidemiology and Director, Clinical Cardiovascular Research at our Albert Einstein College of Medicine. He is also Vice-Chair, Academic Affairs and Attending Physician, Echocardiology and Cardiology at Montefiore. Dr. Rodriguez’s clinical focus is general cardiology, echocardiology, hypertension, heart failure and cholesterol management.</p><p>In 1992, Dr. Rodriguez received his Bachelor of Science at the University of Massachusetts at Amherst. He then attended Columbia University College, receiving both his Doctor of Medicine and Master of Public Health degrees in 1996. In 1996, he began a three-year internship and residency in internal medicine at the New York Presbyterian Hospital. He continued training at this institution and completed a fellowship in cardiovascular diseases in 2002. Dr. Rodriguez then completed an advanced clinical and research fellowship in 2003 at Columbia University’s College of Physicians and Surgeons.</p><p>Expanding on his clinical focus, Dr. Rodriguez’s research investigates cardiovascular epidemiology and the impact of psychosocial and behavioral factors on cardiovascular health. He has shared his work at many of invited presentations and has been published in numerous peer-reviewed journals, abstracts and books.</p><p>From 1989 to 1996, Dr. Rodriguez worked with the United States National Guard as a combat medic. In 2007, he received the Columbia University Medical Center Diversity Faculty Research Award.</p><p>Dr. Rodriguez is board certified by the American Board of Internal Medicine and a member of numerous professional societies, including the American Heart Association, the American College of Cardiology and the American Society of Echocardiography.</p>
Yogita M. Rochlani
Dr. Rochlani's clinical areas of focus include cardiac sarcoidosis, myocarditis, cardiac transplantation, and mechanical circulatory support.<quillbot-extension-portal></quillbot-extension-portal>
Dr. Rochlani's research interests include inflammatory cardiomyopathies, particularly cardiac sarcoidosis, donor selection for transplantation, and factors that impact post-transplant longevity, particularly cardiac allograft vasculopathy. She serves as a principal investigator for a study evaluating the phenotypic profiles and natural history of cardiac sarcoidosis, and as the site principal investigator for the Cardiac Sarcoidosis Multicenter Randomized Controlled Trial evaluating immunosuppressive treatment strategies for the treatment of cardiac sarcoidosis.<quillbot-extension-portal></quillbot-extension-portal>
Samuel J. Rednor
Nephrology and Critical Care.
Dr. Rednor’s research focus is in acute kidney injury (AKI), cardiac arrest, and intubation.
<p>Samuel J. Rednor, DO, is Director of Wellness, Critical Care and Assistant Professor, Medicine at Montefiore Einstein. His clinical focus is nephrology and critical care.</p><p>After earning his Doctor of Osteopathic Medicine at Lake Erie College of Osteopathic Medicine in 2013, Dr. Rednor completed his residency in internal medicine at Southampton Hospital in 2016, where he was Chief Resident for one year. He then completed his renal fellowship at Montefiore in 2018, where he was Chief Renal Fellow during his last year. Dr. Rednor went on to complete an additional fellowship at Montefiore in critical care, which he completed in 2019.</p><p>Dr. Rednor’s research focus is in acute kidney injury (AKI), cardiac arrest, and intubation. His work has been published in peer-reviewed journals and he has given multiple lectures and presentations.</p><p>Dr. Rednor is board certified in Internal Medicine, Nephrology and Critical Care Medicine by the American Osteopathic Board of Internal Medicine. He is a member of the American Society of Nephrology (ASN), the American Osteopathic Association (AOA), the Society of Critical Care Medicine (SCCM) and the American College of Chest Physicians (CHEST). In 2018, Dr. Rednor won the Sharon R. Silbiger Teaching Award for excellence in teaching and in recognition as Outstanding Fellow of the Year from Einstein.</p>
Marjan Rahmanian
<p><span>Dr. Marjan Rahmanian is an Assistant Professor of Medicine and Neurology. She is an Associate Medical Director of Cardiothoracic Intensive Care Unit at Montefiore Medical Center. She is also Medical Director of Physician Assistant Critical Care Residency program. She completed her Internal Medicine residency at Hackensack Meridian Mountainside Medical Center, followed by a fellowship in Critical Care Medicine at Mount Sinai Medical Center. After completing her training, she joined the faculty of the Albert Einstein College of Medicine in New York, where she served as an Associate Director of Cardiothoracic Surgical ICU at Montefiore Medical center. As a cardiac intensivist, Dr. Rahmanian focuses on the management of post heart surgery like CABG, valve replacemant, Mechanical Circulatory Support like,ECMO, LVAD,Impella, heart and lung transplant.</p>
<ol>
<li>Maintaining Hemodynamic and Metabolic Homeostasis in Anheptaic Critically Ill Patients. Khan R, Go R, Kapoor S, Dharshan A, <strong>Marjan</strong> <strong>Rahmanian </strong>, Manasia A, Bassily-Marcus A, Kohli-Seth R, Oropello J, Benjamin E. CHEST. October 2012;142:390A-390A</li>
<li>The Heart Point Sign: An Ultrasonographic Confirmation Of Pneumothorax. R. Khan, M. <strong>Marjan</strong> <strong>Rahmanian</strong>, M. Kaufman, A. Bassily Marcus, J. Oropello. ajrccm-conference.2013.187.1 MeetingAbstracts.A1539</li>
<li>Cardiothoracic Surgical ICU Boot Camp can improve cardiovascular critical care knowledge among trainees. <strong>Marjan Rahmanian, </strong>MD; Lewis Eisen, MD; Adam Keene, MD; Rosemarie Conigliaro, MD; Anthony Carlese, DO ATS2018 Poster Presentation </li>
<li>Midodrine: Breaking New Ground in The Treament of Chylothorax: Dolly Patel, DO; <strong>Marjan Rahmanian, </strong>MD; Javed Iqbal, MD; Scott Scheinin, MD; Joshoua Lee, MD; Harish Seethamraju, MD Chest 2019 Poster Presentation</li>
<li>Lactate Dehydrogenase is Associated with Hemorrhagic Stroke During Extracorporeal Membrane Oxygenation for COVID-19 <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Saeed, O.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Uehara, M.</a>; <strong>Marjan</strong> <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank"><strong>Rahmanian</strong>.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Chen, J. T.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Carlese, A.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Mohamed, A.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Ashley, J.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Mellas, N.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Forest, S.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Goldstein, D.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Jorde, U.</a>.<em>ASAIO Journal ; 68(Supplement 3):19, 2022.</em></li>
<li><a href="https://einstein.pure.elsevier.com/en/publications/hiv-dr-heartkidney-t…; target="_blank">HIV D+/R+ heart/kidney transplantation: First case report</a> <a href="https://einstein.pure.elsevier.com/en/persons/vagish-s-hemmige" target="_blank">Hemmige, V.</a>, <a href="https://einstein.pure.elsevier.com/en/persons/omar-saeed" target="_blank">Saeed, O.</a>, <a href="https://einstein.pure.elsevier.com/en/persons/yoram-a-puius" target="_blank">Puius, Y. A.</a>, <a href="https://einstein.pure.elsevier.com/en/persons/yorg-al-azzi" target="_blank">Azzi, Y.</a>, Colovai, A., Borgi, J., <a href="https://einstein.pure.elsevier.com/en/persons/daniel-j-goldstein" target="_blank">Goldstein, D. J.</a>, Marjan Rahmanian, <a href="https://einstein.pure.elsevier.com/en/persons/anthony-j-carlese" target="_blank">Carlese, A.</a>, <a href="https://einstein.pure.elsevier.com/en/persons/ulrich-p-jorde" target="_blank">Jorde, U. P.</a> & <a href="https://einstein.pure.elsevier.com/en/persons/snehal-r-patel" target="_blank">Patel, S. R.</a>, Mar 2023, In: <a href="https://einstein.pure.elsevier.com/en/persons/anthony-j-carlese" target="_blank">Journal of Heart and Lung Transplantation.</a> 42, 3, p. 406-408 3 p. </li>
<li>Chest Tube Insertion, Needle Thoracostomy, And Pericardiocentesis During In-hospital Cardiac Arrest <a title="Luke Andrea" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247" target="_blank">Luke Andrea</a>, Marjan Rahmanian, <a title="Anthony Carlese" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247" target="_blank">Anthony Carlese</a>, <a title="Ariel Shiloh" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247" target="_blank">Ariel Shiloh</a>, <a title="Rithvik Balakrishnan" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247" target="_blank">Rithvik Balakrishnan</a>, <a title="Aron Soleiman" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247" target="_blank">Aron Soleiman</a>, <a title="Michelle Gong" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247" target="_blank">Michelle Gong</a> and <a title="Ari Moskowitz" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247" target="_blank">Ari Moskowitz</a> Circulation. 2022;146:A247</li>
</ol>